Valuation (48%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.65 | 16.25 |
PEG Ratio (TTM) | 0.06 | 1.67 |
P/S Ratio (TTM) | 1.23 | 2.61 |
P/B Ratio (TTM) | 0.37 | 1.90 |
P/FCF Ratio (TTM) | 4.00 | 11.19 |
Price to 5YR AVG Earnings Ratio | N/A | 14.09 |
Price to 5YR AVG FCF Ratio | N/A | 8.12 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -3.71% | 1,524.40% |
ROE (TTM) | -46.91% | 8.88% |
Net Profit Margin (TTM) | -186.31% | 15.63% |
ROIC 5YR AVG | N/A | 20.64% |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -767.93% | -71.95% | N/A |
Revenue | 108.02% | 2.46% | N/A |
Net Income | -601.32% | -71.44% | N/A |
Cash Flow | 94.70% | -5.73% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 14.78 | 3.15 |
Quick Ratio (TTM) | 14.78 | 4.84 |
D/E Ratio (TTM) | 5.09 | 1.27 |
Interest Coverage (TTM) | -1.13 | 0.64 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 0.32 | 0.38 |
LTL to 5YR AVG FCF | N/A | 6.35 |
Shares Outstanding Growth 5YR AVG | N/A | 4.82% |